Rescue treatment with terlipressin in children with refractory septic shock: a clinical study

Table 1 Clinical characteristics of patients before terlipressin treatment

Patient	Sex	Age (months)	Weight (kg)	Underlying disease	Cause of sepsis	Pediatric Logistic Organ Dysfunction score	Pediatric Risk of Mortality score	Prior ischemia	Other data
1	Male	15	12	No	Meningococcus	34	38	Limbs, cutaneous
2	Female	156	47	No	Meningococcus	22	17	No	Coagulopathy
3	Female	36	15	VATER association (vertebral defects, anorectal atresia, tracheoesophageal fistula, renal anomalies)	Unknown (nosocomial)	32	21	Intestinal	ARDS, coagulopathy
4	Male	144	35	Cranial trauma	Unknown (nosocomial)	30	32	No	ARF, hyperkalemia, refractory intracranial hypertension
5	Male	36	16	No	Meningococcus	43	25	Four limbs (severe), cutaneous, intestinal	ARF, rabdomyolisis, severe metabolic acidosis
6	Male	15	12	No	Meningococcus	24	35	Limbs, cutaneous	No
7	Female	7	7	No	Meningococcus	23	19	Limbs, cutaneous	ARF, coagulopathy
8	Male	46	20	No	Unknown	12	26	No	Severe rabdomyolisis
9	Male	56	32	No	Meningococcus	23	30	No	Prior cardiac arrest
10	Female	2	4	Congenital metabolic disease?	Unknown	22	18	No	ARF, metabolic acidosis
11	Male	156	43	Cerebral palsy	Unknown (nosocomial)	31	19	No	No
12	Male	46	18	No	Meningococcus	23	24	No	Coagulopathy
13	Male	115	39	No	Unknown (pneumococcus?)	20	27	Limbs, cutaneous	Prior cardiac arrest, ARDS, ARF
14	Female	72	25	Rabdomyosarcoma	Staphylococcus aureus	52	43	No	No
15	Male	24	13	No	Meningococcus	33	22	Limbs, cutaneous	ARF, coagulopathy
16	Male	1	4	Propionic acidemia	Staphylococcus aureus	21	24	No	Severe metabolic acidosis

ISSN: 1364-8535